Empamore Tablets 10mg

$0.45 - $0.50
SKU 2732
Generic For Empagliflozin
Manufacturer Morepen Labs Ltd.
Active Ingredient Empagliflozin
ExpiryJanuary 2027
Pack Size Qty Price Per Pill or Unit Price Cart
30 Tablet/s US$ 0.50 US$ 15.00
60 Tablet/s US$ 0.50 US$ 30.00
100 Tablet/s US$ 0.45 US$ 45.0010%US$ 50.00
Add to Compare

Empamore Tablets 10mg (Empagliflozin)

Empamore 10m mg is one of the popular and effective medicines to manage type 2 diabetes. It is a generic name of the popular diabetes drug brand Jardiance, which is also prescribed to patients with cardiovascular problems with type 2 diabetes. Empagliflozin is the main active component present in both medicine.

Remember that Empagliflozin is not recommended to those who are insulin-dependent type 1 diabetic patients. They should take insulin injections under medical prescription. Approved by the FDA, Empagliflozin belongs to a class of drugs called SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). Empamore tablets are available in two dose strengths – 10mg and 25mg. Its 10mg dose is recommended in the majority of type 2 diabetes cases.    

Usually, one tablet of Empagliflozin Empamore 10mg is recommended once daily. One can take this medicine with a glass of water with or without food. Your doctor may increase the dose to 25mg once daily, depending on the condition of the blood sugar. If you have missed a dose, take it as soon as you remember, but do not take two doses combined to make up for a missed dose

Side effects of Empagliflozin tablet

 

This medicine is largely safe to take, but there are some possible side effects in very few cases. Its common side effects include:

 

  • Bladder infection or urinary tract infection
  • Vaginal yeast infection
  • Increased thirst
  • Upper respiratory tract infection
  • Increased urinary frequency
  • Vomiting
  • Hike in cholesterol levels
  • Joint pain
  • Polyuria
  • Constipation
  • Genital yeast infection in men
  • Nausea

 

Seek medical help if any of the side effects persist longer or become bothersome.

Empagliflozin tablets are primarily prescribed to lower blood sugar in people with type 2 diabetes. This medicine also helps in reducing the risks of cardiovascular disease with high blood sugar. People living with certain chronic kidney diseases (CKD) are recommended Empagliflozin 10mg in some cases, as it improves kidney outcomes in a few chronic kidney disease patients. In the cases of CKD, Empagliflozin can reduce the risk of chronological heart disease, fatal cardiovascular problems, and sustained decline in estimated glomerular filtration rate (eGFR). It is not recommended for patients with type 1 diabetes mellitus as Empagliflozin 10mg tablet may increase the risk of diabetic ketoacidosis (increased ketones in blood or urine). Consulting a doctor is a must before considering the medicine for treating your condition.

Empamore Tablets 10mg

What is Empagliflozin and what condition does it treat?

Empagliflozin is an SGLT2 inhibitor medication used to manage type 2 diabetes by helping lower blood sugar levels. Empamore Tablets 10mg contain this active ingredient and work by preventing the kidneys from reabsorbing glucose back into the bloodstream, allowing excess sugar to be removed through urine. This diabetes medication also offers cardiovascular benefits for patients with heart disease and can reduce the risk of hospitalization in those with heart failure. Empagliflozin is typically prescribed alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

How does Empagliflozin work in the body?

Empagliflozin functions as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, targeting specific proteins in your kidneys. Normally, kidneys filter glucose from blood but reabsorb most of it back into circulation. Empamore Tablets 10mg block this reabsorption process, forcing your body to eliminate approximately 60-90 grams of glucose daily through urine. This glucose excretion mechanism lowers blood sugar without stimulating insulin production, which differentiates this antidiabetic agent from other diabetes treatments. The medication also promotes modest weight loss and reduces blood pressure as beneficial secondary effects of its unique mechanism.

How long does Empamore Tablets 10mg take to work?

Empamore Tablets 10mg containing empagliflozin begins working within hours of your first dose, with increased glucose appearing in urine within 1-2 hours. However, measurable improvements in blood sugar levels typically become noticeable after 3-5 days of consistent use. Maximum blood glucose reduction from this SGLT2 inhibitor generally occurs within 4-6 weeks of regular treatment. Cardiovascular benefits and heart failure improvements may take several months to fully manifest. Individual response times vary based on baseline glucose levels, kidney function, and overall diabetes management including diet and physical activity alongside medication.

When and how should I take Empamore Tablets 10mg?

Take Empamore Tablets 10mg once daily, preferably in the morning, with or without food. Swallow the tablet whole with water at approximately the same time each day to maintain consistent empagliflozin levels in your bloodstream. If you miss a dose of this diabetes medication, take it as soon as you remember unless it's nearly time for your next scheduled dose—never double up. Stay well-hydrated throughout treatment as this SGLT2 inhibitor increases urination. Your healthcare provider will determine if 10mg is appropriate or if dosage adjustment is needed based on your glycemic control and kidney function.

Is Empamore Tablets 10mg safe for long-term use?

Empamore Tablets 10mg is designed for ongoing, long-term management of type 2 diabetes and has demonstrated a favorable safety profile in studies extending several years. This SGLT2 inhibitor medication containing empagliflozin has shown sustained benefits for blood sugar control, cardiovascular protection, and kidney function preservation over extended periods. Long-term users should maintain regular monitoring including kidney function tests, blood glucose checks, and foot care examinations. Clinical trials have confirmed that the cardiovascular and renal protective effects of this antidiabetic agent actually increase with continued use, making it suitable for chronic disease management in appropriate patients.

Can I take Empamore Tablets 10mg with other medicines?

Empamore Tablets 10mg can often be combined with other diabetes medications including metformin, insulin, or DPP-4 inhibitors for enhanced blood sugar control. However, this SGLT2 inhibitor may increase hypoglycemia risk when used alongside insulin or sulfonylureas, potentially requiring dose adjustments. Empagliflozin may also interact with diuretics (water pills), increasing dehydration risk, and certain blood pressure medications. Always inform healthcare providers about all medications, supplements, and herbal products you're taking. Some combinations require closer monitoring while others work synergistically. Keep an updated medication list and discuss potential drug interactions before starting any new treatment alongside your diabetes therapy.

How does Empamore Tablets 10mg compare to similar medicines in its class?

Empamore Tablets 10mg contains empagliflozin, which belongs to the SGLT2 inhibitor class alongside dapagliflozin and canagliflozin. All these diabetes medications work similarly by increasing glucose excretion through urine. Empagliflozin distinguishes itself with particularly strong evidence for cardiovascular death reduction and heart failure benefits. This SGLT2 inhibitor has been studied extensively across diverse patient populations. While all gliflozins offer weight loss and blood pressure benefits alongside glucose control, empagliflozin has some of the most comprehensive clinical trial data supporting its use in patients with established heart disease or kidney complications related to type 2 diabetes.

Is the generic Empagliflozin as effective as branded versions?

Generic empagliflozin, including Empamore Tablets 10mg, contains the identical active ingredient at the same strength as branded alternatives and delivers equivalent therapeutic effects for type 2 diabetes management. Regulatory authorities require generic medications to demonstrate bioequivalence, meaning they work in your body the same way as original branded versions. The same blood sugar lowering, cardiovascular protection, and kidney benefits apply. The primary difference lies in inactive ingredients and cost, with generics like Empamore offering significant savings. This SGLT2 inhibitor's effectiveness depends on the empagliflozin molecule itself, which remains unchanged regardless of manufacturer, making generic options a clinically sound, economical choice.

Why do patients choose PremiumRxDrugs for Empamore Tablets 10mg?

Patients select PremiumRxDrugs for their Empamore Tablets 10mg because of competitive pricing on both branded and generic empagliflozin options, making this essential SGLT2 inhibitor more affordable for ongoing diabetes management. The pharmacy's decade-long reputation provides confidence that it provides authentic, manufacturer-sourced medications rather than substandard products. Convenient features include easy prescription refill management, discreet international shipping, and free delivery options that reduce the cost burden of chronic disease treatment. Our licensing to serve multiple countries, including the USA, UK, Australia, and Canada, demonstrates regulatory compliance. For patients managing type 2 diabetes long-term, PremiumRxDrugs offers reliability, authenticity guarantees, and customer-focused service that simplifies medication access.

What are the common side effects of Empagliflozin?

Common side effects of empagliflozin include urinary tract infections, increased urination frequency, and genital yeast infections due to glucose in urine. Some patients experience mild dehydration, dizziness, or thirst, particularly when starting this SGLT2 inhibitor. Other frequent effects include nausea and changes in cholesterol levels. Most side effects are manageable through proper hydration and hygiene practices. Rare but serious reactions include ketoacidosis, kidney problems, and severe urinary tract infections. Women may experience vaginal yeast infections more frequently. These effects typically diminish as your body adjusts to the diabetes medication, though persistent or severe symptoms warrant medical attention for proper management.

Who should avoid taking Empagliflozin?

Empagliflozin should be avoided by individuals with type 1 diabetes, severe kidney disease, or those on dialysis, as this SGLT2 inhibitor requires adequate kidney function to work effectively. People with a history of diabetic ketoacidosis, frequent urinary tract infections, or genital infections should discuss risks carefully. This medication is not recommended during pregnancy or breastfeeding. Patients with severe liver disease, history of pancreatitis, or low blood pressure may need alternative diabetes treatments. Elderly patients require careful assessment due to increased dehydration and fall risks. Anyone allergic to empagliflozin or similar gliflozin medications should choose different antidiabetic options after thorough medical evaluation.

Customer's Review
Copyright © 2026 PremiumRxDrugs. All rights reserved